A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...

She has been denied a life-extending drug because she lives in Wales. The drug, called Enhertu, can give patients with a ...

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...

AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second time ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

Following mixed study results, the partners have backed away from seeking broad clearance of dato-dxd in lung cancer and ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

The U.K. drugmaker also announced plans to drop another $2 billion on expanding its R&D and manufacturing footprint in the ...

Top-selling cancer medicine Tagrisso was a big driver with sales up 3.5% higher than expected, while revenue from newcomer ...

AZ later said that it believes Chinese authorities are looking into whether the company’s employees had illegally imported ...

The company previously said it believes Chinese authorities are probing allegations that employees illegally imported breast-cancer drug Enhertu and liver-cancer treatment Imjudo from Hong Kong, and ...